CDKN1A and colonic neoplasm: GHRH antagonist, JMR-132 causes DNA damage in colon cancer cells, which in turn activates cell-cycle machinery arrest and cell apoptosis through the activation of p53, p21 and Bax, and the suppression of Bcl-2 [29, 32].